31-Dec-2025
TipRanks (Mon, 29-Dec 4:02 AM ET)
Emerson Highlights Strategy for Engineering the Autonomous Future at 2025 Investor Conference
PRNewswire (Thu, 20-Nov 1:00 PM ET)
NYSE Content Advisory: Pre-Market update + BLS Reveals First Look at Labor Market Since September
PRNewswire (Thu, 20-Nov 8:55 AM ET)
PRNewswire (Mon, 17-Nov 9:00 AM ET)
Emerson to Automate Lithium Americas' Thacker Pass Lithium Project
PRNewswire (Tue, 11-Nov 9:00 AM ET)
Market Chameleon (Wed, 5-Nov 2:39 AM ET)
Emerson Reports Fourth Quarter and Full Year 2025 Results; Provides Initial 2026 Outlook
PRNewswire (Wed, 5-Nov 6:55 AM ET)
Emerson Schedules Fourth Quarter and Full Year 2025 Earnings Release and Conference Call
PRNewswire (Wed, 15-Oct 9:03 AM ET)
Founded in 1890 as the first manufacturer of electric fans in North America, Emerson Electric has become a leading industrial automation player through the acquisition of established brands. Emerson organizes its business into seven segments that sell a wide range of automation software, power tools, and automation hardware such as valves, gauges, and switches. In recent years, Emerson divested its climate technology and consumer businesses to become more of a pure-play industrial automation company. The automation of a factory is an enticing long-term proposition for manufacturers, helping reduce accident rates and raise uptime and productivity.
Emerson Electric Company trades on the NYSE stock market under the symbol EMR.
As of December 31, 2025, EMR stock price declined to $132.72 with 1,662,948 million shares trading.
EMR has a beta of 1.35, meaning it tends to be more sensitive to market movements. EMR has a correlation of 0.62 to the broad based SPY ETF.
EMR has a market cap of $74.56 billion. This is considered a Large Cap stock.
Last quarter Emerson Electric Company reported $5 billion in Revenue and $1.62 earnings per share. This fell short of revenue expectation by $-35 million and met earnings estimates .
In the last 3 years, EMR traded as high as $150.27 and as low as $76.94.
The top ETF exchange traded funds that EMR belongs to (by Net Assets): VTI, VOO, IVV, SPY, VTV.
EMR has underperformed the market in the last year with a price return of +8.5% while the SPY ETF gained +17.2%. EMR has also underperformed the stock market ETF in the last 3 month and 2 week periods returning +1.6% and -1.0%, respectively, while the SPY returned +2.7% and +0.7%, respectively.
EMR support price is $133.38 and resistance is $137.20 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that EMR shares will trade within this expected range on the day.
